Submitted:
15 July 2025
Posted:
16 July 2025
You are already at the latest version
Abstract

Keywords:
1. Introduction
2. Materials and Methods
2.1. Defining High-Level HBP Surgery
2.2. Patients
2.3. Defining Sarcopenia
2.4. Data
2.5. Statistical Analysis
3. Results
3.1. Patient Characteristics
3.2. Comparison of Preoperative Statuses in the S and NS Groups
3.3. Comparison of Postoperative Statuses in the S and NS Groups
3.4. Perioperative Changes in serum ALB Levels and Motor Function parameters in the Two Groups
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| ALB | albumin |
| AWGS | Asian Working Group for Sarcopenia |
| BMI | body mass index |
| CD | Clavien–Dindo |
| CONUT | controlling nutritional status |
| HBP | hepato-biliary-pancreatic |
| JSHBPS | Japanese Society of Hepato-Biliary-Pancreatic Surgery |
| NS | non-sarcopenia group |
| PE | pleural effusion |
| PNI | prognostic nutritional index |
| S | sarcopenia group |
| SMI | skeletal muscle index |
| TLC | total lymphocyte count |
References
- Otsubo, T.; Kobayashi, S.; Sano, K.; Misawa, T.; Ota, T.; Katagiri, S.; Yanaga, K.; Yamaue, H.; Kokudo, N.; Unno, M.; et al. Safety-related outcomes of the Japanese Society of Hepato-Biliary-Pancreatic Surgery board certification system for expert surgeons. J Hepatobiliary Pancreat Sci 2017, 24, 252–261. [Google Scholar] [CrossRef] [PubMed]
- Harada, K.; Ida, S.; Baba, Y.; Ishimoto, T.; Kosumi, K.; Tokunaga, R.; Izumi, D.; Ohuchi, M.; Nakamura, K.; Kiyozumi, Y.; et al. Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma. Dis Esophagus 2016, 29, 627–633. [Google Scholar] [CrossRef] [PubMed]
- Lieffers, J.R.; Bathe, O.F.; Fassbender, K.; Winget, M.; Baracos, V.E. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 2012, 107, 931–936. [Google Scholar] [CrossRef] [PubMed]
- Okumura, S.; Kaido, T.; Hamaguchi, Y.; Fujimoto, Y.; Masui, T.; Mizumoto, M.; Hammad, A.; Mori, A.; Takaori, K.; Uemoto, S. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 2015, 157, 1088–1098. [Google Scholar] [CrossRef] [PubMed]
- Peng, P.; Hyder, O.; Firoozmand, A.; Kneuertz, P.; Schulick, R.D.; Huang, D.; Makary, M.; Hirose, K.; Edil, B.; Choti, M.A.; et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 2012, 16, 1478–1486. [Google Scholar] [CrossRef] [PubMed]
- Valero, N. 3rd; Amani, N.; Spolverato, G.; Weiss, M.J.; Hirose, K.; Dagher, N.N.; Wolfgang, C.L.; Cameron, A.A.; Philosophe, B.; Kamel, I.R.; et al. Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. J Gastrointest Surg 2015, 19, 272–281. [Google Scholar] [CrossRef] [PubMed]
- Chen, L.K.; Woo, J.; Assantachai, P.; Auyeung, T.W.; Chou, M.Y.; Iijima, K.; Jang, H.C.; Kang, L.; Kim, M.; Kim, S.; et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc 2020, 21, 300–307. [Google Scholar] [CrossRef] [PubMed]
- Chen, L.K.; Liu, L.K.; Woo, J.; Assantachai, P.; Auyeung, T.W.; Bahyah, K.S.; Chou, M.Y.; Chen, L.Y.; Hsu, P.S.; Krairit, O.; et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014, 15, 95–101. [Google Scholar] [CrossRef] [PubMed]
- Dindo, D.; Demartines, N.; Clavien, P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004, 240, 205–213. [Google Scholar] [CrossRef] [PubMed]
- Onodera, T.; Goseki, N.; Kosaki, G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi 1984, 85, 1001–1005. [Google Scholar] [PubMed]
- Ignacio de Ulibarri, J.; Gonzalez-Madrono, A.; de Villar, N.G.; Gonzalez, P.; Gonzalez, B.; Mancha, A.; Rodriguez, F.; Fernandez, G. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 2005, 20, 38–45. [Google Scholar] [PubMed]
- Botwinick, I.C.; Pursell, L.; Yu, G.; Cooper, T.; Mann, J.J.; Chabot, J.A. A biological basis for depression in pancreatic cancer. HPB (Oxford) 2014, 16, 740–743. [Google Scholar] [CrossRef] [PubMed]
- Agudelo, L.Z.; Femenia, T.; Orhan, F.; Porsmyr-Palmertz, M.; Goiny, M.; Martinez-Redondo, V.; Correia, J.C.; Izadi, M.; Bhat, M.; Schuppe-Koistinen, I.; et al. Skeletal muscle PGC-1a1 modulates kynurenine metabolism and medi.a.;es resilience to stress-induced depression. Cell 2014, 159, 33–45. [Google Scholar] [CrossRef] [PubMed]
- Argiles, J.M.; Campos, N.; Lopez-Pedrosa, J.M.; Rueda, R.; Rodriguez-Manas, L. Skeletal muscle regulates metabolism via interorgan crosstalk: Roles in health and disease. J Am Med Dir Assoc 2016, 17, 789–796. [Google Scholar] [CrossRef] [PubMed]
- Liu, J.; Song, N.; Huang, Y.; Chen, Y. Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway. Sci Rep 2018, 8, 15247. [Google Scholar] [CrossRef] [PubMed]
- Nakajima, H.; Yokoyama, Y.; Inoue, T.; Nagaya, M.; Miuno, Y.; Kadono, I.; Nishiwaki, K.; Nishida, Y.; Nagino, M. Clinical benefit of preoperative exercise and nutritional therapy for patients undergoing hepato-pancreato-biliary surgeries for malignancy. Ann Surg Oncol 2019, 26, 264–272. [Google Scholar] [CrossRef] [PubMed]
- Moran, J.; Guinan, E.; McCormick, P.; Larkin, J.; Mockler, D.; Hussey, J.; Moriarty, J.; Wilson, F. The ability of prehabilitation to influence postoperative outcome after intra-abdominal operation: A systematic review and meta-analysis. Surgery 2016, 160, 1189–1201. [Google Scholar] [CrossRef] [PubMed]
- Fan, S.T.; Lo, C.M.; Lai, E.C.; Chu, K.M.; Liu, C.L.; Wong, J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 1994, 331, 1542–1552. [Google Scholar] [CrossRef] [PubMed]
- Shirabe, K.; Yoshimatsu, M.; Motomura, T.; Takeishi, K.; Toshima, T.; Muto, J.; Matono, R.; Taketomi, A.; Uchiyama, H.; Maehara, Y. Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients. Liver Transpl 2011, 17, 1073–1080. [Google Scholar] [CrossRef] [PubMed]
- Hayashi, K.; Yokoyama, Y.; Nakajima, H.; Nagino, M.; Inoue, T.; Nagaya, M.; Hattori, K.; Kadono, I.; Ito, S.; Nishida, Y. Preoperative 6-minute walk distance accurately predicts postoperative complications after operations for hepato-pancreato-biliary cancer. Surgery 2017, 161, 525–532. [Google Scholar] [CrossRef] [PubMed]
- Nakajima, H.; Yokoyama, Y.; Inoue, T.; Nagaya, M.; Mizuno, Y.; Kadono, I.; Nishiwaki, K.; Nishida, Y.; Nagino, M. Clinical benefit of preoperative exercise and nutritional therapy for patients undergoing hepato-pancreato-biliary surgeries for malignancy. Ann Surg Oncol 2019, 26, 264–272. [Google Scholar] [CrossRef] [PubMed]


| Variable | |
| Age (years) | 72 (20–87) |
| Male/female | 99/56 |
| BMI (kg/m2) | 22.7 (15.8–43.4) |
| Body fat percentage (%) | 27.3 (3.0–54.0) |
| SMI (kg/m2) | 6.8 (4.4–9.1) |
| Diabetes mellitus | 55 (35.5%) |
| ALB (g/dL) | 4.0 (2.4–5.2) |
| PNI | 47 (30–59) |
| CONUT score | 2 (0–9) |
| Gait speed (m/s) | 1.19 (0.52–1.63) |
| Mean grip strength (kg) | 27.7 (13.0–52.0) |
| Variable | S Group (n = 68) | NS Group (n = 87) | P Value |
| Age (years) | 73 (20–86) | 72 (31–87) | 0.15 |
| Male/female | 44/24 | 55/32 | 0.85 |
| BMI (kg/m2) | 21.3 (15.8–28.4) | 24.1 (17.6–43.4) | <0.05 |
| Body fat percentage (%) | 26.9 (9.0– 0.4) | 27.6 (3.0–54.0) | <0.05 |
| Diabetes mellitus | 31 (45.6%) | 24 (27.6%) | <0.05 |
| ALB (g/dL) | 3.8 (2.4–5.2) | 4.0 (2.7–4.6) | <0.05 |
| PNI | 45 (30–59) | 48 (34–57) | 0.06 |
| CONUT score | 2 (0–9) | 2 (0–6) | <0.05 |
| Gait speed (m/s) | 2 (0–9) | 1.26 (0.52–1.53) | 0.06 |
| Mean grip strength (kg) | 25.9 (13.0–38.5) | 31.4 (15.9–52.0) | <0.05 |
| Variable | S Group (n = 68) | NS Group (n = 87) | P Value |
| Postoperative complications | 19 (27.9%) | 22 (25.3%) | 0.71 |
| CD grade ≥ IIa complications | 15 (22.1%) | 12 (13.8%) | 0.18 |
| Refractory ascites and PE | 2 (2.9%) | 1 (1.1%) | 0.42 |
| Postoperative hospital stay (days) | 21 (8–108) | 20 (7–156) | 0.38 |
| 3-month mortality | 1 (1.5%) | 0 | 0.26 |
| ALB at discharge (g/dL) | 3.3 (1.9–4.2) | 3.3 (2.2–4.0) | 0.55 |
| Gait speed at discharge (m/s) | 1.12 (0.69–1.40) | 1.25 (0.53–1.54) | <0.05 |
| Mean grip strength at discharge (kg) | 19.7 (8.5–32.3) | 26.3 (16.2–47.1) | <0.05 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).